Cargando…
Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia
Autores principales: | Li, Zejuan, Huang, Hao, Chen, Ping, He, Miao, Li, Yuanyuan, Arnovitz, Stephen, Jiang, Xi, He, Chunjiang, Hyjek, Elizabeth, Zhang, Jun, Zhang, Zhiyu, Elkahloun, Abdel, Cao, Donglin, Shen, Chen, Wunderlich, Mark, Wang, Yungui, Neilly, Mary Beth, Jin, Jie, Wei, Minjie, Lu, Jun, Valk, Peter J. M., Delwel, Ruud, Lowenberg, Bob, Le Beau, Michelle M., Vardiman, James, Mulloy, James C., Zeleznik-Le, Nancy J., Liu, Paul P., Zhang, Jiwang, Chen, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898456/ https://www.ncbi.nlm.nih.gov/pubmed/29633759 http://dx.doi.org/10.1038/ncomms16192 |
Ejemplares similares
-
miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia
por: Li, Zejuan, et al.
Publicado: (2012) -
MOZ is critical for the development of MOZ/MLL fusion–induced leukemia through regulation of Hoxa9/Meis1 expression
por: Katsumoto, Takuo, et al.
Publicado: (2022) -
miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia
por: Jiang, Xi, et al.
Publicado: (2016) -
MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma
por: Guan, Lei, et al.
Publicado: (2019) -
Mei : per flauto solo (1962)
por: Fukushima, Kazuo
Publicado: (1966)